Known as GLP-1 receptor agonists, the drugs have soared in popularity in recent years, but patient access has been a consistent problem because of their cost...
Scott Olson | Getty Images Snap stock surged 13% on Thursday after announcing a $400 million deal with Perplexity AI and releasing its third-quarter financial results....
